Dec 16, 2024
The US Food and Drug Administration (FDA) has approved Yesintek (ustekinumab-kfce). This is the sixth approved biosimilar to the reference m
#FDAApproved#YesintekBiosimilar#StelaraBiosimilar#BiosimilarApproval#AffordableHealthcare#PlaquePsoriasisTreatment#PsoriaticArthritisCare#CrohnsDiseaseManagement#UlcerativeColitisTherapy#BiologicTherapies#CostEffectiveMedication#InflammatoryDiseaseCare#HealthcareInnovation#FDAApproval2024#AccessToCare#theindianpharma